Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/22387
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Adult,Aged,Aged, 80 and over,Antineoplastic Combined Chemotherapy Protocols/*adverse,effects/pharmacokinetics/*therapeutic use,Doxorubicin/administration & dosage/adverse effects/pharmacokinetics,Drug Administration Schedule,Female,Humans,Liposomes,Male,Maximum Tolerated Dose,Middle Aged,Neoplasms/*drug therapy,Neutropenia/chemically induced,Paclitaxel/administration & dosage/adverse effects/pharmacokinetics
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/22387
ISSN: 0923-7534
Link: http://www.ncbi.nlm.nih.gov/pubmed/15367419
http://annonc.oxfordjournals.org/content/15/10/1566.full.pdf
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Briasoulis-2004-Weekly paclitaxel co.pdf80.72 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons